Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Macular Photocoagulation Study Group
- PMID: 9194725
- DOI: 10.1001/archopht.1997.01100150743009
Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Macular Photocoagulation Study Group
Abstract
Objectives: To verify and quantify previously reported risk factors for development of choroidal neovascularization (CNV) in the fellow eye of patients with 1 eye affected with CNV secondary to age-related macular degeneration, to examine the value of characteristics of the pericentral macula in the quantification of risk for developing CNV, and to explore whether the presence of occult CNV in the first eye affects the development of CNV in the fellow eye.
Design, patients, and setting: Follow-up study of fellow eyes of 670 patients enrolled in multicenter, randomized clinical trials of laser photocoagulation of juxtafoveal or subfoveal CNV.
Main outcome measure: Development of CNV.
Results: Three characteristics of the central macula of the fellow eye and 1 systemic factor were associated independently with an increased risk of developing CNV: the presence of 5 or more drusen (relative risk, 2.1; 95% confidence interval, 1.3-3.5), focal hyperpigmentation (relative risk, 2.0; 95% confidence interval, 1.4-2.9), 1 or more large drusen (relative risk, 1.5; 95% confidence interval 1.0-2.2), and definite systemic hypertension (relative risk, 1.7; 95% confidence interval, 1.2-2.4). Estimated 5-year incidence rates ranged from 7% for the subgroup with no risk factors to 87% for the subgroup with all 4 risk factors. Characteristics of the pericentral macula were not strongly associated with the development of CNV. The presence of occult CNV in the first eye affected had no influence on the development of CNV or on the type of CNV in the fellow eye.
Conclusions: The prognosis of the fellow eye is affected strongly by characteristics of its central macula and by systemic hypertension. These factors should be considered when counseling patients with unilateral neovascular age-related macular degeneration and when targeting patients for preventive interventions.
Similar articles
-
Five-year follow-up of fellow eyes of individuals with ocular histoplasmosis and unilateral extrafoveal or juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group.Arch Ophthalmol. 1996 Jun;114(6):677-88. doi: 10.1001/archopht.1996.01100130669006. Arch Ophthalmol. 1996. PMID: 8639078 Clinical Trial.
-
Persistent and recurrent neovascularization after laser photocoagulation for subfoveal choroidal neovascularization of age-related macular degeneration. Macular Photocoagulation Study Group.Arch Ophthalmol. 1994 Apr;112(4):489-99. doi: 10.1001/archopht.1994.01090160065024. Arch Ophthalmol. 1994. PMID: 7512335 Clinical Trial.
-
Macular scatter ('grid') laser treatment of poorly demarcated subfoveal choroidal neovascularization in age-related macular degeneration. Results of a randomized pilot trial.Arch Ophthalmol. 1996 Dec;114(12):1456-64. doi: 10.1001/archopht.1996.01100140654002. Arch Ophthalmol. 1996. PMID: 8953976 Clinical Trial.
-
Current management of choroidal neovascularization.Ann Ophthalmol. 1988 Nov;20(11):415-20, 423. Ann Ophthalmol. 1988. PMID: 2466432 Review.
-
Age-related macular degeneration and risk factors for the development of choroidal neovascularization in the fellow eye.Curr Opin Ophthalmol. 1998 Jun;9(3):38-46. doi: 10.1097/00055735-199806000-00007. Curr Opin Ophthalmol. 1998. PMID: 10182098 Review.
Cited by
-
Association between Metformin and a Lower Risk of Age-Related Macular Degeneration in Patients with Type 2 Diabetes.J Ophthalmol. 2019 Oct 31;2019:1649156. doi: 10.1155/2019/1649156. eCollection 2019. J Ophthalmol. 2019. PMID: 31781371 Free PMC article.
-
Prognosis of untreated occult choroidal neovascularization.Graefes Arch Clin Exp Ophthalmol. 2007 Mar;245(3):376-84. doi: 10.1007/s00417-006-0424-1. Epub 2006 Oct 27. Graefes Arch Clin Exp Ophthalmol. 2007. PMID: 17072636
-
Genetic analysis of simultaneous geographic atrophy and choroidal neovascularization.Eye (Lond). 2012 Aug;26(8):1106-13. doi: 10.1038/eye.2012.107. Epub 2012 Jun 15. Eye (Lond). 2012. PMID: 22699975 Free PMC article.
-
Safety and Efficacy of Systemic Anti-Scg3 Therapy to Treat Oxygen-Induced Retinopathy.Front Biosci (Landmark Ed). 2022 Apr 19;27(4):130. doi: 10.31083/j.fbl2704130. Front Biosci (Landmark Ed). 2022. PMID: 35468689 Free PMC article.
-
Study protocol on prevalence of non-exudative macular neovascularisation and its contribution to prediction of exudation in fellow eyes with unilateral exudative AMD (EYE-NEON).Eye (Lond). 2023 Oct;37(14):3004-3008. doi: 10.1038/s41433-023-02460-9. Epub 2023 Mar 7. Eye (Lond). 2023. PMID: 36882530 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical